Related Experiment Videos
Is tomotherapy the future of IMRT?
1Department of Medical Physics, Hull and East Yorkshire NHS Trust and Post Graduate Medical Institute, University of Hull and Princess Royal Hospital, Saltshouse Road, Kingston Upon Hull HU8 9HE, UK.
The British Journal of Radiology
|April 27, 2004
Summary
Intensity-modulated radiotherapy (IMRT) is evolving. Helical tomotherapy integrates volumetric imaging for precise, conformal treatments, advancing image-guided cancer therapy beyond conventional linear accelerators.
Area of Science:
- Radiation Oncology
- Medical Physics
- Cancer Treatment Technology
Background:
- Intensity-modulated radiotherapy (IMRT) is a widely adopted cancer treatment technique.
- Conventional IMRT delivery often utilizes linear accelerators (Linacs) with multileaf collimators (MLCs).
- Serial tomotherapy played a key role in popularizing IMRT in the late 1990s.
Purpose of the Study:
- To review the advancements in radiotherapy technology beyond initial IMRT implementation.
- To explore the potential of image-guided therapy for enhanced treatment accuracy and conformality.
- To introduce and examine the features of the helical tomotherapy system.
Main Methods:
- Review of existing Intensity-modulated radiotherapy (IMRT) techniques and technologies.
- Discussion of the integration of volumetric imaging for on-line validation during treatment delivery.
- Exploration of the helical tomotherapy system, combining tomotherapy principles with on-line imaging.
Main Results:
- Helical tomotherapy offers a novel approach by integrating volumetric imaging with tomotherapy.
- This integration facilitates on-line validation, enabling more accurate treatment delivery.
- The system aims to achieve higher levels of treatment conformality compared to conventional methods.
Conclusions:
- The helical tomotherapy system represents a significant evolution in radiotherapy.
- Integration of on-line volumetric imaging is crucial for advancing image-guided cancer therapy.
- This technology holds promise for improving treatment precision and therapeutic outcomes.